TANTA UNIVERSITY

🇪🇬Egypt

Country: 🇪🇬Egypt

Ownership: Private

Established: 1972-01-01

Employees: 1K

Market Cap: -

Website: http://www.tanta.edu.eg

Clinical Trials

Novel Regimens in COVID-19 Treatment

Phase 3

Recruiting

Conditions: COVID
Corona Virus Infection

Interventions: Drug: Nitazoxanide

First Posted Date: 2020-05-11

Last Posted Date: 2020-12-04

Lead Sponsor: Tanta University

Target Recruit Count: 160

Registration Number: NCT04382846

Locations: 🇪🇬
Tanta University, Assiut University, Tanta, Egypt
🇪🇬
Sherief Abd-Elsalam, Tanta, Egypt

Quadratus Lumborum Block Versus Dual Transversus Abdominis Plane and Ilioinguinal/Iliohypogastric Nerve Blocks for Postoperative Analgesia Following Total Abdominal Hysterectomy

Not Applicable

Completed

Conditions: Hysterectomy

Interventions: Procedure: Dual Transversus Abdominis Plane and Ilioinguinal/Iliohypogastric Nerve blocks
Procedure: Quadratus Lumborum Block

First Posted Date: 2020-05-11

Last Posted Date: 2023-11-30

Lead Sponsor: Tanta University

Target Recruit Count: 60

Registration Number: NCT04382274

Locations: 🇪🇬
Amany Afheem, Tanta, Egypt

Erector Spinea Plane Block in Pediatric Hip Surgery

Not Applicable

Completed

Conditions: Postoperative Pain
Opioid Use

Interventions: Procedure: Real ultrasound-guided single shot erector spinae plane block (ESP B)
Radiation: Sham ultrasound-guided single shot erector spinae plane block (ESP B)

First Posted Date: 2020-05-05

Last Posted Date: 2021-02-05

Lead Sponsor: Tanta University

Target Recruit Count: 40

Registration Number: NCT04374396

Locations: 🇪🇬
Faculty of Medicine, Tanta, Algharbia, Egypt

Comparison of Ultrasound Guided Erector Spinae Plane Block and Ultrasound Guided Pericapsular Nerve Group Block for Pediatric Hip Surgery

Not Applicable

Completed

Conditions: Postoperative Pain

Interventions: Procedure: pericapsular nerve group block
Procedure: erector spinae plane block

First Posted Date: 2020-05-04

Last Posted Date: 2022-11-25

Lead Sponsor: Tanta University

Target Recruit Count: 56

Registration Number: NCT04373577

Locations: 🇪🇬
Tarek Abdel Hay, Tanta, El Gharbyia, Egypt

Intraperitoneal Versus Intravenous Dexmedetomidine for Post-operative Analgesia Following Laparoscopic Sleeve Gastrectomy Surgery

Not Applicable

Completed

Conditions: Postoperative Pain After Laparoscopic Sleeve Gastrectomy

Interventions: Procedure: intraperitoneal local anaesthetic instillation

First Posted Date: 2020-04-30

Last Posted Date: 2020-12-08

Lead Sponsor: Tanta University

Target Recruit Count: 105

Registration Number: NCT04370392

Locations: 🇪🇬
Tarek Abdel Hay, Tanta, El Gharbyia, Egypt

Isotretinoin in Treatment of COVID-19

Phase 3

Conditions: COVID-19

Interventions: Drug: Isotretinoin Only Product in Oral Dose Form

First Posted Date: 2020-04-24

Last Posted Date: 2020-09-23

Lead Sponsor: Tanta University

Target Recruit Count: 300

Registration Number: NCT04361422

Ivermectin and Nitazoxanide Combination Therapy for COVID-19

Phase 2

Conditions: COVID-19

Interventions: Combination Product: Ivermectin plus Nitazoxanide
Other: Standard Care

First Posted Date: 2020-04-24

Last Posted Date: 2020-04-24

Lead Sponsor: Tanta University

Target Recruit Count: 100

Registration Number: NCT04360356

Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19

Phase 2

Conditions: COVID-19

Interventions: Other: Standard care
Combination Product: Hydroxychloroquine plus Nitazoxanide

First Posted Date: 2020-04-24

Last Posted Date: 2020-04-24

Lead Sponsor: Tanta University

Target Recruit Count: 100

Registration Number: NCT04361318

Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment

Phase 2

Completed

Conditions: Coronavirus Infection
COVID-19

Interventions: Drug: Chloroquine or Hydroxychloroquine

First Posted Date: 2020-04-20

Last Posted Date: 2021-08-02

Lead Sponsor: Tanta University

Target Recruit Count: 194

Registration Number: NCT04353336

Locations: 🇪🇬
Tanta University, Assiut University, Tanta, Egypt

The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment

Phase 2

Recruiting

Conditions: COVID

Interventions: Drug: Ivermectin

First Posted Date: 2020-04-17

Last Posted Date: 2021-03-10

Lead Sponsor: Tanta University

Target Recruit Count: 300

Registration Number: NCT04351347

Locations: 🇪🇬
Tanta University, Tanta, Egypt

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy